as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹346.4
Change
-8.05 (-2.27%)
Open
₹345.1
Prev. Close
₹354.45
Day High
₹363.0
Day Low
₹343.3
Volume Analysis
Traded
7,249
Delivered
3,182
Delivery %
43.9%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong return on equity (31.6%)
Weaknesses (0)
No signal for this stock
Opportunities (2)
- •Strong 3-year EPS growth (254.3%)
- •Strong 3-year revenue growth (19.8%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹378.2 | ₹370.6 | ₹358.5 | ₹350.9 | ₹338.8 | ₹331.2 | ₹319.1 |
| Fibonacci | ₹370.6 | ₹363.07 | ₹358.43 | ₹350.9 | ₹343.37 | ₹338.73 | ₹331.2 |
| Camarilla | ₹351.82 | ₹350.01 | ₹348.21 | ₹350.9 | ₹344.59 | ₹342.79 | ₹340.98 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-2.09%
1 Week
+5.75%
1 Month
-0.57%
3 Months
+2.8%
6 Months
-25.11%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹110.02
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
45.47%
Net margin 6.8% × asset turnover 3.23x × equity multiplier 2.07x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹472 Cr
P/E (TTM)
9.51
ROE
31.6%
Book Value
₹147.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Modi Naturals Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 55/100. The strongest factor is Growth (87/100), while Liquidity (24/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (31.6%). Strong 3-year EPS growth (254.3%).
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 41.2% CAGR over last 5 years
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company might be capitalizing the interest cost
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Q2 earnings conference call recording uploaded on company website on 17 November 2026.
Modi Naturals to host earnings call on 17 November 2026 for Q2 and H1 FY27 results.
MBPL received OMC ethanol orders for 7.82 crore litres worth about ₹495 crore in ESY 2026-27.
Modi Biotech commenced commercial operations at expanded Chhattisgarh ethanol plant, raising capacity from 282 to 600 KLPD.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 | 147 | 174 | 243 | 157 | 205 |
| Expenses + | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 | 132 | 158 | 219 | 135 | 186 |
| Operating Profit | 2 | -1 | 6 | 13 | 13 | 13 | 16 | 18 | 15 | 16 | 24 | 22 | 19 |
| OPM % | 2.5% | -1.2% | 4.7% | 9.0% | 9.0% | 7.0% | 8.0% | 11.0% | 10.0% | 9.0% | 10.0% | 14.0% | 9.0% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 5 | 0 | 0 |
| Interest | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 3 | 3 |
| Depreciation | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| Profit before tax | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 | 12 | 12 | 26 | 16 | 13 |
| Tax % | 16.0% | -15.0% | 6.0% | 14.0% | 15.0% | 12.0% | 27.0% | 22.0% | 15.0% | 17.0% | 25.0% | 22.0% | 17.0% |
| Net Profit + | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 | 10 | 10 | 20 | 12 | 11 |
| EPS in Rs | 1 | -3 | 1 | 6 | 6 | 6 | 6 | 8 | 8 | 8 | 15 | 9 | 8 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | -2 | -8 | 8 | 76 | 60 | 71 | 59 | 5 | 1 | -3 | 28 | 1 | 39 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 234 | 271 | 291 | 277 | 295 | 388 | 443 | 474 | 418 | 399 | 663 | 719 | 779 |
| Expenses + | 230 | 263 | 288 | 274 | 291 | 381 | 430 | 459 | 412 | 390 | 607 | 645 | 698 |
| Operating Profit | 4 | 9 | 3 | 3 | 4 | 8 | 13 | 15 | 5 | 9 | 56 | 74 | 81 |
| OPM % | 1.8% | 3.3% | 1.0% | 1.2% | 1.5% | 1.9% | 2.9% | 3.2% | 1.3% | 2.3% | 8.0% | 10.0% | 10.0% |
| Other Income + | 0 | 0 | 2 | 1 | 1 | 0 | 4 | 1 | 2 | 1 | 1 | 6 | 5 |
| Interest | 3 | 3 | 3 | 3 | 2 | 3 | 1 | 2 | 4 | 7 | 12 | 8 | 9 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 8 | 8 | 10 |
| Profit before tax | 0 | 4 | 0 | 0 | 2 | 4 | 14 | 13 | 2 | -2 | 38 | 64 | 68 |
| Tax % | -7.0% | 53.0% | 107.0% | 100.0% | 64.0% | -28.0% | 25.0% | 28.0% | 42.0% | -21.0% | 18.0% | 21.0% | — |
| Net Profit + | 0 | 2 | 0 | 0 | 1 | 5 | 11 | 9 | 1 | -1 | 31 | 50 | 53 |
| EPS in Rs | 0 | 2 | 0 | 0 | 1 | 4 | 8 | 7 | 1 | -1 | 23 | 38 | 40 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | 11 | 16 | 7 | -5 | 6 | 32 | — | 7 | -12 | -4 | 66 | 8 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 20 | 30 | 31 | 40 | 45 | 55 | 65 | 69 | 77 | 108 | 159 | 182 |
| Borrowings + | 35 | 36 | 33 | 31 | 33 | 21 | 51 | 142 | 170 | 149 | 161 | 166 |
| Other Liabilities + | 20 | 22 | 23 | 29 | 30 | 33 | 37 | 38 | 46 | 59 | 73 | 86 |
| Total Liabilities | 87 | 99 | 97 | 113 | 120 | 121 | 165 | 263 | 306 | 330 | 407 | 448 |
| Fixed Assets + | 18 | 20 | 19 | 20 | 19 | 19 | 26 | 27 | 149 | 145 | 214 | 207 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91 | 0 | 16 | 19 | 28 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 68 | 80 | 78 | 94 | 100 | 102 | 139 | 144 | 157 | 169 | 174 | 214 |
| Total Assets | 87 | 99 | 97 | 113 | 120 | 121 | 165 | 263 | 306 | 330 | 407 | 448 |
| Equity Capital | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -7 | -7 | -8 | 2 | -7 | 1 | 9 | -13 | -6 | -7 | 49 | 61 |
| Cash from Investing Activity + | 0 | 0 | -2 | -1 | -2 | -1 | 2 | -13 | -91 | -32 | -28 | -72 |
| Cash from Financing Activity + | 6 | 7 | 11 | -3 | 8 | 1 | -12 | 30 | 95 | 37 | -21 | 124 |
| Net Cash Flow | -1 | 0 | 1 | -1 | 0 | 1 | -1 | 4 | -2 | -2 | 0 | 113 |
| Free Cash Flow | -7 | -7 | -10 | 2 | -8 | 0 | 11 | -26 | -96 | -40 | 21 | -19 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -152 | -78 | -232 | 68 | -163 | 22 | 87 | -63 | -35 | -65 | 90 | 96 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 30.85% | 30.91% | 30.91% | 30.9% | 30.91% | 30.91% | 30.92% | 30.91% | 30.91% | 30.91% | 30.9% | 30.9% |
| Promoters | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% | 69.09% |
| DII | 0.06% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Modi Naturals Limited (this stock) | 472 | 9.51 | 2.41 | 31.6% |
| The Ugar Sugar Works Ltd | 482 | 7.04 | 2.78 | 60.2% |
| Sukhjit Starch & Chem Ltd | 484 | 10.7 | 0.82 | 1.47% |
| Mcleod Russel India Ltd. | 443 | 7.61 | -30.07 | 788.0% |
| Sarveshwar Foods Limited | 436 | 13.2 | 0.89 | 8.62% |
| Kn Agri Resources Limited | 513 | 14.6 | 1.27 | 8.86% |
| Linc Limited | 516 | 19.0 | 1.99 | 13.2% |
Which Mutual Funds Hold Modi Naturals Limited?
Frequently Asked Questions about Modi Naturals Limited
Modi Naturals Limited (MODINATUR) closed at ₹346.4 on NSE on 19 November 2026, down 8.05 (2.27%) from the previous close.
Modi Naturals Limited trades on the NSE (National Stock Exchange of India) under the symbol MODINATUR.
Modi Naturals Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 9.51.
Modi Naturals Limited has a dividend yield of 0.0%.
Modi Naturals Limited's 52-week high is ₹526.0 and its 52-week low is ₹252.0.
Modi Naturals Limited has a market capitalisation of ₹472 crore.
Modi Naturals Limited has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Modi Naturals Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.